InvestorsHub Logo
Followers 38
Posts 5017
Boards Moderated 2
Alias Born 08/05/2002

Re: None

Friday, 04/22/2022 9:31:04 PM

Friday, April 22, 2022 9:31:04 PM

Post# of 9139
Welp,

The 10K for 2021 was filed this afternoon. $8.9 million in cash at 12/31. In line with what I expected. Given that cash amount, and drop off of Dahl and Rice finally in 1st Qtr and frankly not expecting to see any great R&D going on I'd estimate roughly $7 mil in cash at 3/31/22.

The rest of the 10K reads like a perpetuation of Dahlisms and provides little insight into anything new. I did like seeing the dozens of patents issued or in process worldwide.

So the 10k is out of the way. Now it's in Payne's hands to make it happen.

JMHO, I think Payne needs to land any agreement with a pharma. R&D .... cash, license, equity stake, commercial sales of human ingredient. Still don't know why human GRAS was declared and the ingredient sits for 3 years with nothing done. Still also don't know why human test not done to increase the human daily dosage. It ain't rocket science and would take all that much time and money. I've always wanted to see ZIVO do side by side compare on algae vs glucosamine. Also wanted to see ingredient added to a recovery drink. Don't understand WTH Dahl was doing for 3 years on this. I get COVID. But company didn't try to make something happen there either when money was being tossed about freely for options. This is part of problem where company doesn't have inside scientists unless they can do it in the Ft Myers lab.

WE NEED TO HEAR FROM YOU MR PAYNE. Don't care what it is. Could be awful puff piece. Need to hear something.... anything.

Amigo Mike
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ZIVO News